Jeffrey Allen Bailey Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity

Jeffrey Allen Bailey is Director of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 22,775 shares of AUPH, which is worth approximately $349,596. The most recent transaction as insider was on Nov 21, 2025, when has been sold 2,716 shares (Common Shares) at a price of $15.68 per share, resulting in proceeds of $42,586. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.8K

10.65% 3M change

10.65% 12M change

Total Value Held $349,596

Jeffrey Allen Bailey Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 21 2025	SELL Payment of exercise price or tax liability	$42,586 $15.68 p/Share	2,716 Reduced 10.65%	22,775 Common Shares
Nov 21 2024	BUY Grant, award, or other acquisition	-	12,135 Added 32.25%	25,491 Common Shares
Nov 11 2024	SELL Open market or private sale	$38,415 $8.43 p/Share	4,557 Reduced 25.44%	13,356 Common Stock
Nov 08 2024	BUY Exercise of conversion of derivative security	-	17,913 Added 50.0%	17,913 Common Stock

Also insider at

BDSI

BIODELIVERY SCIENCES INTERNATIONAL INC Healthcare

Chief Executive Officer

THW

Tekla World Healthcare Fund Financial Services

Director

ALRN

AILERON THERAPEUTICS INC Healthcare

Director

JAB